Cefminox
Cefminox[edit]
Cefminox is a cephalosporin antibiotic used in the treatment of various bacterial infections. It belongs to the second generation of cephalosporins and is known for its broad-spectrum activity against both Gram-positive and Gram-negative organisms.
Mechanism of Action[edit]
Cefminox works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, which leads to the interruption of cell wall synthesis and ultimately causes bacterial cell death. This mechanism is similar to other beta-lactam antibiotics.
Clinical Uses[edit]
Cefminox is primarily used to treat infections caused by susceptible bacteria. These include:
- Respiratory tract infections
- Urinary tract infections
- Intra-abdominal infections
- Skin and soft tissue infections
Pharmacokinetics[edit]
Cefminox is administered via intravenous or intramuscular injection. It is well-distributed in body tissues and fluids, achieving therapeutic concentrations in various sites of infection. The drug is primarily excreted unchanged in the urine, which makes it effective for treating urinary tract infections.
Side Effects[edit]
Common side effects of cefminox include:
- Gastrointestinal disturbances such as nausea and diarrhea
- Allergic reactions, including rash and anaphylaxis
- Hematological effects such as leukopenia and thrombocytopenia
Resistance[edit]
Bacterial resistance to cefminox can occur through various mechanisms, including the production of beta-lactamase enzymes that degrade the antibiotic. Resistance can also arise from alterations in PBPs or decreased permeability of the bacterial cell wall.
